Federal public insurance plan enters ACA marketplace to compete on price

What it does

This bill creates a federal public health insurance option to be offered through the Affordable Care Act's insurance marketplaces starting in 2027. The plan would be administered by the federal government, offer bronze/silver/gold tiers, set premiums to cover its own costs, and negotiate provider payment rates (defaulting to Medicare rates if negotiations fail). It aims to increase competition and affordability in the individual insurance market.

Why we flagged it

The bill's core mechanism is the establishment and operation of a federal public health plan competing in ACA marketplaces. This is a direct public-sector insurance offering, not a regulatory change or subsidy to private insurers.

What the text implies

• Provider payment rates defaulting to Medicare levels may reduce reimbursement for some services, potentially affecting provider participation and network breadth in rural or underserved areas.
• The bill authorizes 'such sums as may be necessary' for start-up and operations without a specific appropriation cap, creating open-ended fiscal exposure dependent on enrollment and claims experience.
• State Advisory Councils are optional and non-binding, limiting state input into a federally operated program affecting state health care markets and provider networks.
• The public option's ability to negotiate drug prices separately from Medicare may create two-tier pricing, affecting pharmaceutical company revenue models and potentially drug availability.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Ordinary citizens gain a new competitive insurance choice with federal cost controls and provider-rate negotiation, potentially lowering premiums and expanding access. The bill contains no liability shields, carve-outs, or restrictions on citizens' remedies—it is a straightforward expansion of public insurance options.

Who stands to gain

• uninsured and underinsured individuals (lower-cost coverage option)
• health care providers participating in Medicare (automatic network inclusion)

Named in the bill

Department of Health and Human Services (HHS/Secretary), ACA Exchanges, Medicare (fee-for-service program), Medicaid, State Advisory Councils, Health care providers, Pharmaceutical companies, Private health insurers (indirect competitive pressure)

Where it stands

1 cosponsor: 1 Democrats.

• Jan 8, 2026 — Introduced · Congress.gov: “Introduced in Senate”
• Jan 8, 2026 — Referred to Senate Committee on Health, Education, Labor, and Pensions · Congress.gov: “Read twice and referred to the Committee on Health, Education, Labor, and Pensions”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

1 lobbying clients named this bill on 2 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $5,643,000 in lobbying spend. A filing names 103 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 0% of bills with at least one filing.

Sheldon Whitehouse, the sponsor, reported $52,000 in PAC receipts in the 2026 cycle.

• American Medical Association — $5,643,000 on 2 filings

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.